
|Videos|March 1, 2022
Dr. Eric Klein discusses how IsoPSA works for prostate cancer risk assessment
Author(s)Urology Times staff
“IsoPSA is a way of measuring all the different PSA-related proteins in the blood,” says Eric A. Klein, MD.
Advertisement
In this video, Eric A. Klein, MD, provides an overview of the IsoPSA test and how it works. Klein is Emeritus Professor and Chair of the Glickman Urological & Kidney Institute at Cleveland Clinic and Cleveland Clinic Lerner College of Medicine in Cleveland, Ohio.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants fast track designation to Enolen for localized prostate cancer
2
High PHI scores are linked to increased odds of significant prostate cancer
3
Trial to evaluate novel combination in BCG-unresponsive NMIBC
4
Dosing begins in trial of alpha radioligand therapy for mCRPC
5


















